Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitomycin C associated hemolytic uremic syndrome.

S Jain, A E Seymour

    Pathology
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Mitomycin C-associated Hemolytic Uremic Syndrome (HUS) is a rare, fatal condition affecting 10% of patients. This syndrome involves anemia, thrombocytopenia, and kidney failure, often leading to death.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Glomerular size and glomerulosclerosis in Australian aborigines.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2000
    Same author

    Ultrastructural appearance of renal and other basement membranes in the Bull terrier model of autosomal dominant hereditary nephritis.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2000
    Same author

    Solitary cellular schwannoma (neurilemmoma) showing malignant changes: evaluation through magnetic resonance imaging (M.R.I.), surgical intervention, and histopathology.

    The Journal of dermatology·1999
    Same author

    Analysis, expression and prevalence of the Mycobacterium tuberculosis homolog of bacterial virulence regulating proteins.

    FEMS microbiology letters·1999
    Same author

    Rehydration of air-dried smears. An alternative method for cytologic analysis of exfoliative cells.

    Acta cytologica·1999
    Same author

    Fine needle aspiration cytology and core biopsy histology in infiltrating syringomatous adenoma of the breast. A case report.

    Acta cytologica·1999

    Area of Science:

    • Nephrology
    • Oncology
    • Pathology

    Background:

    • Mitomycin C is an antineoplastic agent used in treating various cancers.
    • Mitomycin C-associated Hemolytic Uremic Syndrome (HUS) is a rare but severe adverse effect.
    • This condition presents with microangiopathic hemolytic anemia, thrombocytopenia, and progressive renal failure.

    Observation:

    • The study details a case of a 65-year-old gastric adenocarcinoma patient who developed HUS during Mitomycin C treatment.
    • Renal failure and thrombocytopenia were observed approximately 8-10 months after initiating Mitomycin C therapy.
    • The patient ultimately succumbed to pulmonary edema, highlighting the high mortality rate.

    Findings:

    • Renal pathology in Mitomycin C-associated HUS includes arteriolar fibrin thrombi, expanded subendothelial zones, and mesangiolysis.

    Related Experiment Videos

  • These renal lesions are histopathologically similar to those observed in idiopathic HUS.
  • Endothelial cell damage induced by Mitomycin C is the proposed mechanism of action.

    • Implications:

    • Increased recognition of Mitomycin C-associated HUS is crucial for early diagnosis and management.
    • Understanding the mechanism of endothelial damage may lead to preventative strategies.
    • This case underscores the significant risks associated with Mitomycin C treatment, particularly in renal and pulmonary systems.